Download Info Pack
Why Cordlife
Why Cordlife

Most Advanced Technology

When it comes to cord blood banking, we go all out for quality to safeguard your family’s health. That is why we always insist on the best so that our clients can receive better medical therapy outcome. Unlike other processing and cryopreservation technologies, our carefully selected technology has never been recalled by the manufacturers.

Sepax®2 The world’s only fully automated cord blood processing technology

  • Trusted by majority of the world’s leading cord blood banks
  • Used by a large number of the public and private cord blood banks worldwide including over 85% of the leading public banks in the NetCord Organization
  • Able to achieve as high as 99.88%^ Total Nucleated Cells (TNC) recovery rate
  • Closed processing system prevents any contamination
  • Fully automated. Processes one cord blood unit at a time to prevent possible cross-contamination

MVE Vapour-Phase Liquid Nitrogen Storage System

  • Reduces cross-contamination
  • Trusted by majority of private cord blood banks worldwide
  • Lowest sample temperature at -190°C

*Cord blood stem cells remain at cryopreservation condition as long as they are stored below Glass Transition Temperature (-135°C)

MVE Vapour-Phase Nitrogen Storage
Storage Media Characteristics

Vapour is a much safer medium than liquid phase to largely reduce the risk of cross-contamination between cord blood units.

Cross-contamination Record No record.

Majority of private cord blood banks worldwide including Cord Blood Registry and Viacord use vapour freezers only. Client accountability is important for private banks as the cord blood units are legally owned by clients.

Control Difficulty

Design of the vapour freezer's lid allows operator to monitor and arrange cord blood units properly with ease. Clients' unique cord blood samples can be retrieved easily anytime.

Potential of Machine Failure

Zero. MVE system does not rely on electricity to operate.

Recall record


Cordlife's Guarantee

The findings confirm that an increase in the time interval between collection and processing negatively affects the quality of the UCB sample, viablecells and CD34+ cells statistically significant decrease compared to the difference in the means at 24 and 72 hours*
Cordlife Guarantee Source: Does the time between collecting and processing umbilical cord blood samples affect the quality of the sample? einstein. 2011; 9(2 Pt 1):207-11

CellOptima Patented Technology

Cordlife-Available exclusively in Hong Kong,

Unlike conventional technology that can harvest Mesenchymal stem cells (MSCs) only, Cordlife’s exclusive patented breakthrough technology can isolate and expand not just Mesenchymal Stem Cells (MSCs) but also Epithelial Stem Cells (EpSCs) from your baby’s umbilical cord tissue. With CellOptima, you can give your family that additional protection coverage that you have always wanted. This technology is only available at Cordlife. Learn more about CellOptima

CellOptima Patented Technology